Study identifies new metrics to enhance scRNA-seq based virtual cell modelling Foundational paper to drive development of improved virtual cell models for rejuvenation target discovery…
Read More
SB000 reverses cellular ageing as measured by DNA methylation clocks in multiple cell types without loss of cellular identity or signs of pluripotency Study advances…
Read More
Lord David Prior appointed as Chair of the Board, previously Chairman of NHS England and member of the UK Life Sciences Council Sir Tony Kouzarides,…
Read More
Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor Laurence Reid joins as Non-Executive Director, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Millennium Pharmaceuticals Cambridge,…
Read More
Head of Machine Learning, Lucas Camillo (centre right) to lead team with Professor Bo Wang, University of Toronto (centre) appointed as Senior Advisor Expansion into…
Read More
#112 Defeating the Diseases of Aging with Daniel Ives from Shift Bioscience About Shift Bioscience Shift Bioscience is a biotech company uncovering the biology of…
Read More
Shift Bioscience Head of ML Lucas Camillo and advisor Bo Wang released CpGPT, a foundation model for DNA methylation. Lucas used a fine-tuned CpGPT to…
Read More
Investment led by BGF, with support from existing investors F-Prime Capital, Kindred Capital, and Jonathan Milner Seed funding will accelerate development of Shift Bioscience’s platform…
Read More
British biotech races US’s ‘buff billionaires’ for secret of eternal youth An article in the Guardian on rejuvenation race has mentioned Shift Bioscience. Read on…
Read More
Live Long and Prosper Shift Bioscience's Daniel Ives features in Cambridge University's Enterprising Minds. Find out more on the Cambridge University website. About Shift Bioscience…
Read More